HALO logo
halo search icon
Agios Pharmaceuticals, Inc.

US$28.79

Price Change Indicator
0.29 (1.02%)
Agios Pharmaceuticals, Inc.
AGIO · NAS

Agios Pharmaceuticals, Inc.

Start Trading AGIO for Free

US$28.79

Price Arrow0.29 (1.02%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHammer BullishHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Agios Pharmaceuticals, Inc. Overview

AGIO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About AGIO

icon
icon

Telephone

1.617.649.8600

icon

Address

88 Sidney Street, Cambridge, MA 02139-4169

Description

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

AGIO Price Chart

Key Stats

Market Cap

US$1.69B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 22.24 - 46

Trade Value (12mth)

US$7,990,463.00

1 week

1.17%

1 month

6.66%

YTD

4.86%

1 year

-3.68%

All time high

138.85

Key Fundamentals

EPS 3 yr Growth

68.30%

EBITDA Margin

-864.30%

Operating Cashflow

-$373m

Free Cash Flow Return

-26.70%

ROIC

-29.50%

Interest Coverage

0.00

Quick Ratio

11.10

Other Data

Shares Outstanding (Fully Diluted)

59m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AGIO Announcements

Latest Announcements

DateAnnouncements
29 April 26
29 April 26
29 April 26
13 February 26
12 February 26

AGIO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-6.3311.86-7.12locklocklock
EPS (Fully Diluted)
 $locklocklocklock-6.3311.64-7.12locklocklock
Growth
 %locklocklocklock-49.5287.5-160locklocklock
PE
 XlocklocklocklockN/A2.8N/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Agios Pharmaceuticals, Inc. (AGIO:NAS)?
Halo FAQ
The current share price of Agios Pharmaceuticals, Inc. (AGIO:NAS) is USD$28.79.
What is the 52-week high share price for Agios Pharmaceuticals, Inc. (AGIO:NAS)?
Halo FAQ
The 52-week high share price for Agios Pharmaceuticals, Inc. (AGIO:NAS) is USD$46.00.
What is the 52-week low share price for Agios Pharmaceuticals, Inc. (AGIO:NAS)?
Halo FAQ
The 52-week low share price for Agios Pharmaceuticals, Inc. (AGIO:NAS) is USD$22.24.
What is the dividend yield for Agios Pharmaceuticals, Inc. (AGIO:NAS)?
Halo FAQ
Agios Pharmaceuticals, Inc. (AGIO:NAS) does not pay a dividend.
What was Agios Pharmaceuticals, Inc. (AGIO:NAS) last dividend payment?
Halo FAQ
Agios Pharmaceuticals, Inc. (AGIO:NAS) does not pay a dividend.
What is the franking level for Agios Pharmaceuticals, Inc. (AGIO:NAS)?
Halo FAQ
Agios Pharmaceuticals, Inc. (AGIO:NAS) has a franking level of 0.00%.
In which sector is Agios Pharmaceuticals, Inc. (AGIO:NAS) classified?
Halo FAQ
Agios Pharmaceuticals, Inc. (AGIO:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial